New combo therapy shows promise for advanced skin cancer
Disease control
Ongoing
This trial tests a new drug, EVX-01, combined with the standard immunotherapy pembrolizumab in 17 adults with advanced melanoma that cannot be removed by surgery. The goal is to see if adding EVX-01 improves tumor shrinkage compared to historical data with pembrolizumab alone. Pa…
Phase: PHASE2 • Sponsor: Evaxion Biotech A/S • Aim: Disease control
Last updated May 13, 2026 16:03 UTC